Late-onset neutropenia following rituximab treatment in patients with autoimmune diseases
Author:
Publisher
Wiley
Subject
Dermatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2133.2007.08189.x/fullpdf
Reference14 articles.
1. Rituximab in the adjuvant treatment of pemphigus vulgaris: a prospective open-label pilot study in five patients
2. Delayed-onset peripheral blood cytopenia after rituximab: Frequency and risk factor assessment in a consecutive series of 77 treatments
3. A high incidence of late-onset neutropenia following rituximab-containing chemotherapy as a primary treatment of CD20-positive B-cell lymphoma: a single-institution study
4. Rituximab maintenance improves clinical outcome of relapsed/resistant follicular non-Hodgkin lymphoma in patients both with and without rituximab during induction: results of a prospective randomized phase 3 intergroup trial
5. Maintenance therapy with rituximab leads to a significant prolongation of response duration after salvage therapy with a combination of rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) in patients with recurring and refractory follicular and mantle cell lymphomas: results of a prospective randomized study of the German Low Grade Lymphoma Study Group (GLSG)
Cited by 42 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Hematologic Toxicity of Drug Therapy;Comprehensive Dermatologic Drug Therapy;2021
2. Rituximab in practice: Clinical evaluation of patients with pemphigus after rituximab administration;Dermatologic Therapy;2020-12-15
3. Drug-Induced Neutropenia During Treatment of Non-Neoplastic Dermatologic Diseases: A Review;Clinical Drug Investigation;2020-07-21
4. Rituximab‐mediated late onset neutropenia in autoimmune blistering diseases: negligible or under‐estimated threat?;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2020-07-12
5. Patterns of B Cell Repletion Following Rituximab Therapy in a Pediatric Rheumatology Cohort;ACR Open Rheumatology;2019-08-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3